mianserin การใช้

Mianserin was the first antidepressant to reach the UK market that was less dangerous than the tricyclic antidepressants in overdose.
Of the antidepressants, amitriptyline may reduce depression, but mianserin, fluoxetine, fluvoxamine, and phenelzine sulfate showed no effect.
It was chemically derived via altering the chemical structure of the tetracyclic ( " atypical " ) antidepressant, mianserin.
Similarly to its analogue, mirtazapine, mianserin has been tried as an augmentation strategy in treatment-resistant depression with some success.
Mianserin has demonstrated efficacy as a monotherapy for the treatment of Parkinson's disease psychosis in an open-label clinical trial.